173 related articles for article (PubMed ID: 267252)
1. Cancer risks from estrogen intake.
Greenwald P; Nasca PC; Caputo TA; Janerich DT
N Y State J Med; 1977 Jun; 77(7):1069-74. PubMed ID: 267252
[No Abstract] [Full Text] [Related]
2. Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.
Sperling MA
West J Med; 1975 Jan; 122(1):42-9. PubMed ID: 1089006
[No Abstract] [Full Text] [Related]
3. Evaluation of current information concerning the relationship between hormonal usage and cancer.
Hertz R
Clin Obstet Gynecol; 1977 Mar; 20(1):165-75. PubMed ID: 837580
[No Abstract] [Full Text] [Related]
4. Is the pill carcinogenic?
Drug Ther Bull; 1975 Dec; 13(26):103-4. PubMed ID: 173513
[No Abstract] [Full Text] [Related]
5. Role of exogenous female hormones in altering the risk of benign and malignant neoplasms in humans.
Thomas DB
Cancer Res; 1978 Nov; 38(11 Pt 2):3991-4000. PubMed ID: 212185
[TBL] [Abstract][Full Text] [Related]
6. Are oral contraceptives and diethylstilbestrol (tdes) involved in sex-linked cancer?
Edgren RA
Curr Top Mol Endocrinol; 1976; 4():95-106. PubMed ID: 829221
[No Abstract] [Full Text] [Related]
7. Cancer and the use of estrogens.
Gambrell RD
Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
[TBL] [Abstract][Full Text] [Related]
8. [Oral contraception and cancers of the uterus and the breast].
Vokaer R
J Gynecol Obstet Biol Reprod (Paris); 1974; 3(3):379-400. PubMed ID: 4470735
[No Abstract] [Full Text] [Related]
9. Vaginal and cervical cancers associated with exposure in utero to diethylstilbestrol.
J Tenn Med Assoc; 1977 May; 70(5):340-2. PubMed ID: 865116
[No Abstract] [Full Text] [Related]
10. [Lesions of the uterine cervix during oral contraception].
De Brux J
Sem Hop; 1974 May; 50(22):1491-5. PubMed ID: 4369604
[No Abstract] [Full Text] [Related]
11. [Oral contraception and cancer risk].
Genton CY
Schweiz Med Wochenschr; 1981 Nov; 111(46):1742-8. PubMed ID: 6274005
[TBL] [Abstract][Full Text] [Related]
12. [Oral contraceptives and menopausal estrogens in relation to breast neoplasia].
Brzezinski A; Schenker JG
Harefuah; 1983 Jun; 104(11-12):520-3. PubMed ID: 6680711
[No Abstract] [Full Text] [Related]
13. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
J Fla Med Assoc; 1977 Feb; 64(2):96-8. PubMed ID: 839195
[No Abstract] [Full Text] [Related]
14. Editorial: Prenatal exposure to stilboestrol.
Med J Aust; 1975 Mar; 1(12):373-4. PubMed ID: 1143126
[No Abstract] [Full Text] [Related]
15. Stilboestrol and human cancer.
Bishun NP; Smith NS; Williams DC
Clin Oncol; 1977 Mar; 3(1):75-80. PubMed ID: 862278
[No Abstract] [Full Text] [Related]
16. [Estrogen/progestogen-exposure and fetal effects].
Forsberg JG
Tidsskr Nor Laegeforen; 1977 Oct; 97(30):1583-4. PubMed ID: 929540
[No Abstract] [Full Text] [Related]
17. [Hormonal contraception and the growth of neoplasm].
Haller J
Med Klin; 1974 Feb; 69(7):272-86. PubMed ID: 4132852
[No Abstract] [Full Text] [Related]
18. [Clear cell adenocarcinoma of the cervic and vagina (report of a case)].
Coronel RJ; Díaz Palacios R
Ginecol Obstet Mex; 1976 Jun; 39(236):429-33. PubMed ID: 947825
[No Abstract] [Full Text] [Related]
19. Oral contraceptives: considerations of safety in nonclinical distribution.
Atkinson L; Castadot R; Cuadros A; Rosenfield AG
Stud Fam Plann; 1974 Aug; 5(8):242-9. PubMed ID: 4602364
[No Abstract] [Full Text] [Related]
20. Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
Hertz R
Int J Fertil; 1968; 13(4):273-86. PubMed ID: 4882601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
